Abstract
A series of new, structurally simple trichostatin A (TSA)-like straight chain hydroxamates were prepared and evaluated for their ability to inhibit partially purified human histone deacetylase 1 (HDAC-1). Some of these compounds such as 8m, 8n, 12, and 15b exhibited potent HDAC inhibitory activity with low nanomolar IC(50) values, comparable to natural TSA. These compounds induce hyperacetylation of histones in T24 human cancer cells and significantly inhibit proliferation in various human cancer cells. They also induce expression of p21 and cause cell cycle blocks in human cancer cells. In this paper, we describe the synthesis of these new compounds as well as structure-activity relationship results from enzyme inhibition and alterations in cellular function.
MeSH terms
-
Acetylation
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology
-
Blotting, Western
-
Cell Division / drug effects
-
Cyclin-Dependent Kinase Inhibitor p21
-
Cyclins / biosynthesis
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Histone Deacetylase Inhibitors*
-
Histones / drug effects
-
Humans
-
Hydroxamic Acids / chemical synthesis
-
Hydroxamic Acids / chemistry*
-
Hydroxamic Acids / pharmacology
-
Recombinant Proteins / antagonists & inhibitors
-
Structure-Activity Relationship
-
Tumor Cells, Cultured
Substances
-
Antineoplastic Agents
-
CDKN1A protein, human
-
Cyclin-Dependent Kinase Inhibitor p21
-
Cyclins
-
Enzyme Inhibitors
-
Histone Deacetylase Inhibitors
-
Histones
-
Hydroxamic Acids
-
Recombinant Proteins
-
trichostatin A